We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




New Study Shows MRIs Are Safe for Patients with Implantable Devices

By HospiMedica International staff writers
Posted on 10 Oct 2017
The results of a new study show that Magnetic Resonance Imaging (MRI) appears to be safe for patients with various implantable cardiac devices such as defibrillators, and pacemakers, and even for chest imaging.

MRI scanning has long been considered dangerous for patients with implantable cardiac devices, but the new study shows that MRI can be safely performed on such patients after all.

The researchers from the Intermountain Medical Center Heart Institute (Salt Lake City, UT, USA) published the results of their study in September 28, 2017, issue of the Journal of Clinical Electrophysiology. More...
The researchers evaluated the MRI studies of 178 patients with cardiac implantable electronic devices, between February 2014 and August 2016, but could not find any problems that needed to be fixed. The study however did not investigate the safety of an MRI scan in direct proximity to the implantable cardiac rhythm devices.

According to the authors, the new study confirms that MRI can safely be used to scan the heart or lungs in patients with implantable devices, and confirms the MagnaSafe findings.

Senior author of the study, Jeffrey L. Anderson, MD, said, "Magnetic resonance imaging has become very popular. It's excellent for looking at soft tissue changes. But it involves very high-strength magnetic fields, which means if a patient has any implanted metal devices containing iron, it could potentially cause harm. X-rays can see bone, but they don't provide much information about soft tissues like the brain, the heart or other internal organs. MRIs are marvelous for that. That's a pretty big number of leads exposed to these very strong MRI fields. You would think if there were even a one percent chance of having a problem, it would have shown up. Not even one generator or lead needed more than a minor adjustment, if any at all."

Related Links:
Intermountain Medical Center Heart Institute


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Autoclave
Advance
X-Ray System
Leonardo DR mini III
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.